Figure 1.
Co-application of glutamate and glycine evokes a Ca2+ signal associated with activation of NMDARs through an NR2B independent pathway. (A1–3) Typical fluorescence images of cortical neurons labelled with Fura-2 (380 nm excitation) (Scale Bar: 100 μm; A1). Intracellular calcium signals (grey – 27 individual and black – average calcium traces recorded from cultured neurons in A1) following 2 successive co-applications of glutamate and glycine (2 min; dots; A2). Calcium traces indicate that there is no detectable difference between the 2 successive Ca2+ responses evoked by the co-application of glutamate/glycine. Bar charts comparing the amplitude for Ca2+ responses evoked by 2 successive co-application of glutamate/glycine (ncult = 9; ncells = 275; A3). (B1–3) Intracellular Ca2+ signals (black–average calcium traces recorded from 19 neurons in B1 and 37 neurons in B2) following 2 successive applications of glutamate/glycine (2 min; dots) in control condition (1st application) and in presence of the broad-spectrum NMDAR antagonist MK801 (40 μM; B1) or a specific blocker of the NR2B sub-unit Ifenprodil (2 μM; B2). The 2nd Ca2+ response induced by the co-application of glutamate/glycine is totally blocked by MK801 (B1) but not by Ifenprodil (B2). Bar chart summarizing the significant inhibitory effect of MK801 (ncult = 8; ncells = 271) and the lack of effect of Ifenprodil (ncult = 7; ncells = 299) on Ca2+ responses evoked by the co-application of glutamate/glycine (B3). Results are presented as means ± SEM (***p < 0.005; paired t-test).